Tools & Technology The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics. Jan 19, 2023 Caris Life Sciences Raises $400M in Senior Secured Debt Financing Jan 10, 2023 Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test Jan 10, 2023 Prenetics' ACT Genomics Profiling Test for Solid Tumors Receives FDA Clearance Jan 9, 2023 Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform Jan 6, 2023 Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses Jan 6, 2023 Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis Jan 5, 2023 AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform Jan 5, 2023 Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response Jan 4, 2023 FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek Dec 30, 2022 Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers Dec 29, 2022 Study Shows Potential of Drug Sensitivity Profiling With Sequencing for Pediatric Cancers Dec 28, 2022 Mission Bio, Abiosciences to Develop Analytics For Studying Hematologic Cancers Dec 22, 2022 Predictive Oncology Wants to Improve Precision Cancer Rx Development With AI-Driven Platform Premium Dec 20, 2022 Multiomic Study Points to New Colorectal Cancer Risk Contributors Dec 20, 2022 Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M Dec 16, 2022 Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK Dec 15, 2022 Leukemia Patients See Survival Benefit With Integrated Functional Drug, Molecular Testing Approach Premium Dec 15, 2022 Pangea Biomed Nets Additional $5M in Seed Funds Dec 14, 2022 NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform Dec 13, 2022 Envisagenics, Cancer Research UK, Queen Mary University Collaborate on AML Drug R&D Load More Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
